Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-23T23:58:00.525Z Has data issue: false hasContentIssue false
  • English
  • Français

Epidemiology of Vancomycin-Resistant Enterococci Among Patients on an Adult Stem Cell Transplant Unit: Observations From an Active Surveillance Program

Published online by Cambridge University Press:  02 January 2015

Michael S. Calderwood ,
Andreas Mauer ,
Jocelyn Tolentino ,
Ernesto Flores ,
Koen van Besien ,
Ken Pursell  and
Stephen G. Weber
Michael S. Calderwood
Affiliation:
Pritzker School of Medicine, University of Chicago, University of Chicago Medical Center, Chicago, Illinois
Andreas Mauer
Affiliation:
Pritzker School of Medicine, University of Chicago, University of Chicago Medical Center, Chicago, Illinois
Jocelyn Tolentino
Affiliation:
Section of Infectious Diseases, University of Chicago Medical Center, Chicago, Illinois Infection Control Program, University of Chicago Medical Center, Chicago, Illinois
Ernesto Flores
Affiliation:
Infection Control Program, University of Chicago Medical Center, Chicago, Illinois
Koen van Besien
Affiliation:
Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois
Ken Pursell
Affiliation:
Section of Infectious Diseases, University of Chicago Medical Center, Chicago, Illinois
Stephen G. Weber*
Affiliation:
Section of Infectious Diseases, University of Chicago Medical Center, Chicago, Illinois Infection Control Program, University of Chicago Medical Center, Chicago, Illinois
*
Section of Infectious Diseases, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 5065, Chicago, IL 60637 (sgweber@medicine.bsd.uchicago.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To use the findings of an active surveillance program to delineate the unique epidemiology of vancomycin-resistant enterococci (VRE) in a mixed population of transplant and nontransplant patients hospitalized on a single patient care unit.

Design.

Surveillance survey and case-control analysis.

Setting.

A 19-bed adult bone marrow and stem cell transplant unit at a referral and primary-care center.

Patients.

The study included patients undergoing transplantation, patients who had previously received bone marrow or stem cell transplants, and patients with other malignancies and hematological disorders who were admitted to the study unit.

Methods.

Patients not previously identified as colonized with VRE had perirectal swab specimens collected at admission and once weekly while hospitalized on the unit. The prevalence of VRE colonization at admission and the incidence throughout the hospital stay, genotypes of VRE specimens as determined by pulsed field gel electrophoresis, and risk factors related to colonization were analyzed.

Results.

There was no significant difference in the prevalence or incidence of new colonization between nontransplant patients and prior or current transplant recipients, although overall prevalence at admission was significantly higher in the prior transplant group. Preliminary genotypic analysis of VRE isolates from transplant patients suggests that a proportion of cases of newly detected VRE carriage may represent prior colonization not detected at admission, with different risk factors suggestive of a potential epidemiological distinction.

Conclusion.

Examination of epidemiological and microbiological data collected by an active surveillance program provides useful information about the epidemiology of VRE that can be applied to inform rational infection control strategies.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 11 , November 2008 , pp. 1019 - 1025
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Cosgrove, SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006;42:S82–S89.Google Scholar
2.Kaye, KS, Engemann, JJ, Mozaffari, E, Carmeli, Y. Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis 2004;10:1125–1128.CrossRefGoogle ScholarPubMed
3.Carmeli, Y, Eliopoulos, G, Mozaffari, E, Samore, M. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 2002;162:2223–2228.CrossRefGoogle ScholarPubMed
4.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al.SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362–386.CrossRefGoogle ScholarPubMed
5.Shadel, BN, Puzniak, LA, Gillespie, KN, Lawrence, SJ, Kollef, M, Mundy, LM. Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications. Infect Control Hosp Epidemiol 2006;27:1068–1075.Google Scholar
6.Price, CS, Paule, S, Noskin, GA, Peterson, LR. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 2003;37:921–928.CrossRefGoogle ScholarPubMed
7.Muto, CA, Giannetta, ET, Durbin, LJ, Simonton, BM, Farr, BM. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002;23:429–435.CrossRefGoogle ScholarPubMed
8.Weinstock, DM, Conlon, M, Iovino, C, et al.Colonization, bloodstream infection, and mortality caused by vancomycin-resistant Enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2007;13:615–621.CrossRefGoogle ScholarPubMed
9.Matar, MJ, Tarrand, J, Raad, I, Rolston, KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 2006;34:534–536.CrossRefGoogle ScholarPubMed
10.Edmond, MB, Ober, JF, Weinbaum, DL, et al.Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126–1133.Google Scholar
11.Tenover, FC, Arbeit, RD, Goering, RV, et al.Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.CrossRefGoogle ScholarPubMed
12.Assadian, O, Askarian, M, Stadler, M, Shaghaghian, S. Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran. BMC Infect Dis 2007;7:52.Google Scholar
13.Suntharam, N, Lankford, MG, Trick, WE, Peterson, LR, Noskin, GA. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis 2002;43:183–188.CrossRefGoogle ScholarPubMed
14.Palladino, S, Kay, ID, Flexman, JP, et al.Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay. J Clin Microbiol 2003;41:2483–2486.CrossRefGoogle ScholarPubMed
15.Petrich, AK, Luinstra, KE, Groves, D, Chernesky, MA, Mahony, JB. Direct detection of vanA and vanB genes in clinical specimens for rapid identification of vancomycin resistant enterococci (VRE) using multiplex PCR. Mol Cell Probes 1999;13:275–281.CrossRefGoogle ScholarPubMed
16.Satake, S, Clark, N, Rimland, D, Nolte, FS, Tenover, FC. Detection of vancomycin-resistant enterococci in fecal samples by PCR. J Clin Microbiol 1997;35:2325–2330.CrossRefGoogle ScholarPubMed
17.D'Agata, EM, Webb, G, Horn, M. A mathematical model quantifying the impact of antibiotic exposure and other interventions on the endemic prevalence of vancomycin-resistant enterococci. J Infect Dis 2005;192:2004–2011.CrossRefGoogle ScholarPubMed
18.Perencevich, EN, Fisman, DN, Lipsitch, M, Harris, AD, Morris, JG Jr, Smith, DL. Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units. Clin Infect Dis 2004;38:1108–1115.CrossRefGoogle ScholarPubMed